


Simulations Plus (SLP) delivered earnings and revenue surprises of +29.63% and +13.51%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus shares soar 9% after topping Q2 estimates
NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
NEW YORK, Jan. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Simulations Plus (SLP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The consensus price target hints at a 33.6% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Simulations Plus posted weak Q3 2025 results, including a $77.2M impairment and cut guidance, sending shares down 25.8% to $12.97 on July 15, 2025.
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simulations Plus lowers FY25 revenue forecast and restructures operations as biotech headwinds hit services demand.
Der Sektor "Healthcare" liegt aktuell im Mittelfeld aller Sektoren. In der letzten Woche gab es eine bahnbrechende Mitteilung durch die FDA, die für deutlichen Schwung in die Kursbewegungen einiger Titel...
Simulations Plus fiscal Q2 2025 performance gains from its strong software solutions and services portfolio amid limited customer funding.
Simulations Plus (SLP) delivered earnings and revenue surprises of 24% and 3.11%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?